title: Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.
abstract: Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described. In both cases, lithium was remarkably effective and no severe side-effects occurred. These findings suggest that lithium can be a useful antidepressant agent in the treatment of depressive SLE patients.
authors.affiliation: Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Terao
authors.forename: T
authors.initials: T
authors.lastname: Mizuki
authors.forename: T
authors.initials: T
authors.lastname: Ohji
authors.forename: K
authors.initials: K
authors.lastname: Abe
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000523:psychology; D008803:Mianserin / Q000009:adverse effects / Q000627:therapeutic use; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000523:psychology; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000523:psychology
chemical_list: D000305:Adrenal Cortex Hormones; D008803:Mianserin; D008094:Lithium; D011239:Prednisolone